跳到正文
原文
Medical Xpress·· 2026-10-08精选AI 评分62

牛津大学研究:人小胶质细胞经GPNMB介导的trogocytosis清除神经元内α-synuclein聚集

Brain immune cells protect neurons in Parkinson's disease by 'nibbling' harmful material

AI 导读

牛津大学团队在Science Translational Medicine发表研究,利用人iPSC来源的多巴胺能神经元与小胶质细胞共培养模型,发现一类活化小胶质细胞可通过trogocytosis选择性移除神经元内含α-synuclein聚集的部分,同时保留神经元整体结构与功能。

推荐理由

在人类iPSC模型中发现小胶质细胞可选择性清除神经元内α-synuclein聚集,并指向GPNMB这一环节,为机制研究提供切入点。

正文
Brain immune cells protect neurons in Parkinson's disease by 'nibbling' harmful material
Microglia cells positive for lectins (brown). Credit: Grzegorz Wicher, Public Domain

Researchers at the University of Oxford have uncovered a previously unrecognized protective role for microglia, the brain's resident immune cells, in Parkinson's disease. The study shows that a distinct population of human microglia can selectively remove harmful clumps (aggregates) of the Parkinson's-causing protein alpha-synuclein from dopamine-producing neurons. The research is published in the journal Science Translational Medicine.

Parkinson's disease affects more than 10 million people worldwide. The disease is characterized by the progressive loss of dopamine-producing neurons and the buildup of abnormal clumps of the protein alpha-synuclein within nerve cells. Identifying new potential ways of preventing or removing these clumps could enable new treatments to slow or stop the progression of Parkinson's disease.

Microglia are the brain's resident immune cells, acting as its first line of defense and helping to keep the brain healthy. They respond to damage, clear away cellular debris and help shape connections between nerve cells, but when persistently activated, they can contribute to inflammation and damage to neurons.

Nibbling away harmful protein aggregates

The researchers developed human stem cell models (derived from induced pluripotent stem cells (iPSCs) that allow human dopamine-producing neurons and microglia to be studied together. The team examined how microglia responded when alpha-synuclein aggregates formed inside neurons, either as a consequence of increased alpha-synuclein gene dosage or after exposure to alpha-synuclein fibrils that act as a "template," encouraging the endogenous neuronal protein to misfold the same way.

The researchers found that microglia were able to reduce the harmful alpha-synuclein aggregates associated with Parkinson's disease by selectively removing small portions of the neuron through a process known as trogocytosis, in which cells "nibble" material from another cell.

This reveals a new mechanism through which microglia can remove harmful material while preserving the overall structure and function of the neuron.

Dr. Hung-Ju Chueh, first author of the study, said, "What is striking is the precision of this response. The microglia were not simply engulfing damaged neurons but instead removing parts of the neuron containing aggregated alpha-synuclein, suggesting that, at certain stages of disease, microglia help neurons dispose of potentially harmful material."

Signals keep protective microglia in check

This response was fine-tuned by both sensing (P2RY12) and inhibitory (CD22) signals between the two cell types, as well as a "self-regulated brake" on microglia mediated by the cytokine IL-10, which stops them from damaging healthy tissue.

Using single-cell RNA sequencing, a technique that allowed them to examine the gene profiles of individual cells, the researchers identified a subpopulation of activated microglia associated with this beneficial clearance response.

Professor George Tofaris, senior author of the study, said, "Our findings highlight that the immune response in Parkinson's disease is more nuanced than simply being beneficial or harmful.

"We have identified a population of human microglia that can actively remove pathological alpha-synuclein from neurons. Understanding how to enhance and monitor such beneficial microglial functions, without triggering damaging inflammation, could open up new avenues for developing disease-modifying treatments."

GPNMB supports aggregate clearance

Tofaris adds, "We also found that the protein glycoprotein nonmetastatic melanoma protein B (GPNMB) appears to be an important part of this protective process. Genetic variation at the GPNMB locus has previously been associated with Parkinson's disease through genome-wide association studies, but the functional role of GPNMB in disease has remained unclear."

The researchers found that GPNMB was upregulated and interacted with pathological alpha-synuclein within microglia when they were exposed to neurons containing aggregates. GPNMB was also increased in microglia within the substantia nigra, the brain region most affected in Parkinson's disease, in tissue from individuals with incidental alpha-synuclein pathology or Parkinson's disease.

When the researchers selectively reduced GPNMB expression in microglia using genetic approaches (CRISPRi), the cells became less effective at clearing alpha-synuclein aggregates from neurons, providing evidence that GPNMB plays an active role in this protective process.

Publication details

HungJu Chueh et al, Human microglia clear intraneuronal alpha-synuclein aggregates by GPNMB-mediated trogocytosis, Science Translational Medicine (2026). DOI: 10.1126/scitranslmed.adz9258. www.science.org/doi/10.1126/scitranslmed.adz9258

Journal information: Science Translational Medicine

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Brain immune cells protect neurons in Parkinson's disease by 'nibbling' harmful material (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-brain-immune-cells-neurons-parkinson.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com